JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Drilon
    Drilon
  2. Berger
    Berger
  3. Ladanyi
    Ladanyi
  4. Schram
    Schram
  5. Chakravarty
    Chakravarty
  6. Solit
    Solit
  7. Gao
    Gao
  8. Robson
    Robson
  9. Schultz
    Schultz
  10. Young
    Young

Groups

  1. Department of Medicine (15)
  2. Early Drug Development Service (15)
  3. Solid Tumor Oncology Division (15)
  4. Department of Pathology and Laboratory Medicine (11)
  5. Thoracic Oncology (9)
  6. GSK Faculty (8)
  7. Gynecologic Medicine Service (8)
  8. Human Oncology and Pathogenesis Program (7)
  9. Weinberg Fellows (7)
  10. Breast Medicine Service (6)
Search Within
  1. "Early Drug Development Service"
Formats
  1. Journal Article (15)
Groups
  1. Department of Medicine (15)
  2. Early Drug Development Service (15)
  3. Solid Tumor Oncology Division (15)
  4. Department of Pathology and Laboratory Medicine (11)
  5. Thoracic Oncology (9)
  6. GSK Faculty (8)

More Groups

People
  1. David Hyman (13)
  2. Ahmet Zehir (6)
  3. Alexander Drilon (6)
  4. Alison Schram (5)
  5. Jose Baselga (5)
  6. Marc Ladanyi (5)

More People

Years
  1. 2025 (1)
  2. 2021 (2)
  3. 2019 (7)
  4. 2018 (2)
  5. 2017 (3)
Publishers
  1. American Society of Clinical Oncology (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of BRCA-altered uterine sarcoma treated with poly(ADP-ribose) polymerase inhibitors
    Journal Article

    Rao, M.; Merrill, M.; Troxel, M.; Chiang, S.; Momeni-Boroujeni, A.; Hensley, M. L.; Schram, A. M.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Spectrum of BRAF mutations and gene rearrangements in ovarian serous carcinoma
    Journal Article

    Chui, M. H.; Chang, J. C.; Zhang, Y.; Zehir, A.; Schram, A. M.; Konner, J.; Drilon, A. E.; da Cruz Paula, A.; Weigelt, B.; Grisham, R. N.
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Utility of serial cfDNA NGS for prospective genomic analysis of patients on a phase I basket study
    Journal Article

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, D. S.; Houck-Loomis, B.; You, D.; Samoila, A.; Schiavon, G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Combined PIK3CA and FGFR inhibition with alpelisib and infigratinib in patients with PIK3CA-mutant solid tumors, with or without FGFR alterations
    Journal Article

    Hyman, D. M.; Tran, B.; Paz-Ares, L.; Machiels, J. P.; Schellens, J. H.; Bedard, P. L.; Campone, M.; Cassier, P. A.; Sarantopoulos, J.; Vaishampayan, U.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation: An open-label, single-arm cohort of the histology-independent VE-Basket study
    Journal Article

    Subbiah, V.; Gervais, R.; Riely, G.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M.; Gonçalves, A.; Italiano, A.; Keedy, V.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis of metastatic non–clear-cell renal cell carcinoma to identify therapeutic targets
    Journal Article

    Carlo, M. I.; Khan, N.; Zehir, A.; Patil, S.; Ged, Y.; Redzematovic, A.; Coskey, D. T.; Hyman, D. M.; Ladanyi, M.; Chen, Y. B.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates CNS efficacy in TRK fusion-positive solid tumors
    Journal Article

    Rosen, E. Y.; Schram, A. M.; Young, R. J.; Schreyer, M. W.; Hechtman, J. F.; Shu, C. A.; Ku, N. C.; Hyman, D. M.; Drilon, A.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology